AZN 250103 69.00C (AZN250103C69000) Stock Options, News & Quotes

US OptionsDetailed Quotes

AZN250103C69000

Watchlist

0.03
0.000.00%

15min DelayClose Jan 3 16:00 ET

0.00High0.00Low

Intraday

5D
Daily

News

AstraZeneca, Daiichi Sankyo Win US FDA Nod for Breast Cancer Treatment Datroway
MT NewswiresJan 19 03:57 ET
AstraZeneca's Datroway Approved in U.S. for HER2-negative Breast Cancer Patients
TipRanksJan 17 17:35 ET
Unusual Options Activity: MSTR, HRL and Others Attract Market Bets, MSTR V/OI Ratio Reaches 129.7
Moomoo NewsJan 17 16:30 ET
AstraZeneca, Daiichi Sankyo Antibody-drug Conjugate Dato-DXd Gains FDA Nod
Seeking AlphaJan 17 14:12 ET
AstraZeneca Said to Have Changed Management of Its China Unit
Seeking AlphaJan 17 10:36 ET
Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks
MT NewswiresJan 17 09:18 ET

Comments

Stock_Drift

Jan 18 08:51

$GlaxoSmithKline (GSK.US)$ $Amgen (AMGN.US)$ $AstraZeneca (AZN.US)$

Ozempic, Xtandi among next 15 drugs selected for U.S. price talks

Stock_Drift

Jan 17 17:48

$AstraZeneca (AZN.US)$

Phil Dunn

Jan 12 00:08

Weekly Trading Report (2nd Week Jan)

A Quick Review of my Trading Activities in this week ( 6 - 10 Jan 2025 ).
Market Overview
- US 10 Year Treasury yield is rising continuously because of high inflation expectation ( fear of high US tariffs ) and strong US economy ( low unemployment rate and strong consumers spending ).
- US 10 Year Treasury yield is approaching 5% ( 5% was highest record since Fed hiked rate last 2 years ) and put large downward pressure to stock markets broadly. ( Yield curren...

December CPI comes in as expected, is that enough?

Meltyy

Dec 17, 2024 01:56

📌 1 PDUFA this weekand 6 more upcoming this month! 🚀

🔔 This Week’s PDUFA:
$Ionis Pharmaceuticals (IONS.US)$ : 🤔
⇨ IONIS-APOCIII-LRx (Olezarsen)
‣ FCS (Familial chylomicronemia syndrome)
‣ PDUFA: 12/19/24 (NDA)
🗓️ Last Week’s PDUFA Decisions:
$Checkpoint Therapeutics (CKPT.US)$ : Approved 12/13/24 ✅
⇨ UNLOXCYT (cosibelimab-ipdl)
‣ metastatic or locally advanced cSCC (cutaneous squamous cell carcinoma)
‣ PDUFA: 12/28/24 (resubmitted BLA)
$Neurocrine Biosciences (NBIX.US)$ : Approved 12/13/24 ✅
⇨ CRENESSITY™ (crin...

10xStockPicks

Dec 15, 2024 18:30

A.i Predicts Big Pharma Will Soon Acquire Esperion Therapeutics for $12 to $16 A share, Current Price $2.25

$Esperion Therapeutics (ESPR.US)$ Acquiring Esperion Therapeutics could be a strategic move for a big pharmaceutical company for several compelling reasons. Here are the main factors that suggest an acquisition could be beneficial for a larger player in the pharmaceutical industry:
1. Unique Market Position in Statin Alternatives
– Addressing Statin Intolerance: There are millions of statin...